Fireside Chat (May 11th 8-9am PT)

Conversation With A Medtech Visionary

In this conversation, we'll tap into the experiences, wisdom and projections of medtech mogul, Paul LaViolette.  We'll learn what Paul and his partners are up to with their new Medtech Convergence Fund and we'll have some fun talking about stories from the past and opportunities of the future.  

Scott Pantel

Scott Pantel

CEO, Life Science Intelligence

Moderator

Paul LaViolette

Paul LaViolette

Managing Partner, SV Health Investors, Medtech Convergence Fund

Fireside Chat

Keynote (May 12th 8-9am PT)

Medtech 3.0 & Creating Unicorns

Scott will deliver a Keynote address on May 12th and share his vision for the future of medtech and why now is the time to build, not backpedal.  He'll share insights and experiences from the past and provide his unique perspective on the opportunities ahead.  His session will address thinking big during the COVID era and the digital transformation to improve access to care, lower cost and improve patient outcomes.

Huennekens has more than 25 years of experience in the medical device industry, specializing in clinical advancement through innovative R&D and technology-based initiatives. He currently serves as Executive Chairman of the Board for Acutus Medical (IPO in 2020).  He has held a number of executive leadership roles within the healthcare industry, accelerating the next generation of digital surgery for Verb Surgical and leading Volcano Corporation, an image guided therapy device company, to its IPO in 2006. He holds an MBA from Harvard University and a BS in Business Administration from the University of Southern California. Huennekens currently sits on the boards of public companies Viewray and NuVasive.

Scott Huennekens

Scott Huennekens

Chairman Of The Board, Vida FLaSH Acquisitions

Keynote

Featured Speaker (May 13th 8-9am PT)

Predicting What's Next

On February 19, 2020 during his keynote speech at LSI2020, Chris outlined what was in store for the world when a nascent viral outbreak in a Chinese city most had never heard of began to infect locals. Today the predictions seem eerie, as they were delivered only months before the world went into quarantine, economies crumbled and nearly three million died. For many, LSI2020 was the last time we were able to assemble in a group…and equally, the upcoming annual conference is likely the first in-person event for most of us in over a year. As we prepare to come together, many are wondering "what lies ahead?” and “could this happen again?”. At LSI2021, Chris will share his predictions for the future. 

Christopher J. Velis

Christopher J. Velis

Founder & Executive Chairman, Miraki Innovation

Featured Industry Address

Strategic Panel (May 11th 11-Noon PT)

Deal-Making and Strategic Partnering

In this panel we'll look at medtech M&A coming out of COVID.  What kind of deals are strategics looking for?  How has their strategy changed (or not changed) as a result of what we've learned?  What deals will see in 2021 and beyond?

The panel will be moderated by industry insider and Alira Health Senior Partner & VP, David Uffer.

Finn Haley

Finn Haley

VP Corporate Development, Edwards Lifeciences

Panelist

Vanessa Abate Green

Vanessa Abate Green

VP Corporate Development, Zimmer Biomet

Panelist

Matthew Schopp

Matthew Schopp

Director, Business Development, Philips

Panelist

Nicholas Pachuda

Nicholas Pachuda

Senior Vice President, J&J Innovation (former), Peptilogics (current)

Panelist

Ramin Mousavi

Ramin Mousavi

VP & Global Franchise Leader, Baxter

Panelist

David Uffer

David Uffer

Senior Partner & VP, Alira Health

Moderator

Investor Panel (May 11th 7-8pm PT)

Investing in Medtech Innovation: What Do VCs Want?

In this panel we'll talk to active VCs about the types of deals they are in now and we'll find out what new deals they are looking for in 2021 and beyond. 

The panel will be moderated by Lisa Carmel.  Lisa is an industry insider, VP of Strategy with Ximedica,  and she advises top medtech startups and accelerators, while also serving on the board of various organizations.

Terri Burke

Terri Burke

Venture Partner, Epidarex Capital

Panelist

Kyle Dempsey, MD

Kyle Dempsey, MD

Partner, MVM Partners

Panelist

Dennis McWilliams

Dennis McWilliams

Partner, Sante Ventures

Panelist

Christopher J. Velis

Christopher J. Velis

Founder & Executive Chairman, Miraki Innovation

Panelist

Allan May

Allan May

Venture Partner, Medtech Convergence Fund, Co-Founder, Life Science Angels

Panelist

Lisa Carmel

Lisa Carmel

Vice President Strategy, Ximedica

Moderator

Reimbursement & Patient Access Panel (May 12th 1;30-2:30pm PT)

Integrating a Strategic Approach to Reimbursement and Patient Access: From Concept Through Commercialization

This panel discussion will provide insight from an experienced group of medtech investors, industry executives, and commercialization & reimbursement consultants that will inform the go to market strategy for attendees from emerging medtech organizations.  The panel will be moderated by industry leader, Tom Keating, CIO of PRIA Healthcare Management, LLC.

Tom Keating

Tom Keating

Chief Innovation Officer, PRIA Healthcare Management, LLC

Moderator

Kelli Hallas

Kelli Hallas

Vice President, PRIA Healthcare Management, LLC

Panelist

Joel Brill

Joel Brill

Chief Medical Officer, Predictive Health

Panelist

John Chaparro

John Chaparro

Investor & Serial Startup Entrepreneur, AngelMed

Panelist

Michelle Smith

Michelle Smith

Director, Market Access and Custom Analytics, Intuitive

Panelist

-->

Our Clients